13063_2019_3346_MOESM2_ESM.docx (26.98 kB)
Additional file 2: of MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
journal contribution
posted on 2019-05-09, 05:00 authored by Antonio Uccelli, Alice Laroni, Lou Brundin, Michel Clanet, Oscar Fernandez, Seyed Nabavi, Paolo Muraro, Roberto Oliveri, Ernst Radue, Johann Sellner, Per Soelberg Sorensen, Maria Sormani, Jens Wuerfel, Mario Battaglia, Mark FreedmanSupplementary materials. (DOCX 27 kb)